BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6088337)

  • 1. [Relation between concentrations of ceftizoxime in bile and the gallbladder wall and blood levels and clinical application of the drug to surgical patients].
    Ferri O; Bagni CM; Marinoni M; Fumagalli G; Fanfani A; Meinardi G
    G Ital Chemioter; 1984; 31(1-2):121-5. PubMed ID: 6088337
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftizoxime sodium (Cefizox).
    Med Lett Drugs Ther; 1983 Dec; 25(650):109-10. PubMed ID: 6318059
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ceftizoxime and its place in the context of modern cephalosporins].
    Nitti V
    Clin Ter; 1986 May; 117(3):233-60. PubMed ID: 3524975
    [No Abstract]   [Full Text] [Related]  

  • 4. [Review [New antibiotics series VI]: Ceftizoxime (author's transl)].
    Shimizu K; Shimada J
    Jpn J Antibiot; 1982 Apr; 35(4):869-83. PubMed ID: 6285027
    [No Abstract]   [Full Text] [Related]  

  • 5. Biliary excretion of ceftizoxime in humans.
    Brogard JM; Arnaud JP; Timmler R
    Chemotherapy; 1984; 30(4):221-6. PubMed ID: 6086245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on ceftizoxime in children (author's transl)].
    Kobayashi Y; Haruta T; Tsutsui T; Kuroki S; Okura K; Tsuji S; Ouchi T; Yamakawa M
    Jpn J Antibiot; 1982 Jan; 35(1):137-51. PubMed ID: 6279905
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue penetration characteristics of ceftizoxime and cefazolin in human bile and gallbladder wall.
    Cunha BA; Ristuccia AM; Jonas M; Ristuccia PA; Janelli DE
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():117-20. PubMed ID: 6295996
    [No Abstract]   [Full Text] [Related]  

  • 8. A selective clinical trial of ceftizoxime.
    Anania WC; Chinkes SL; Rosen RC; Turner PR; Helfand AE
    J Am Podiatr Med Assoc; 1987 Dec; 77(12):648-52. PubMed ID: 3323468
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of ceftizoxime in the treatment of critically ill patients infected with multiply antibiotic resistant bacteria.
    Scully BE; Neu HC
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():141-50. PubMed ID: 6295999
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with ceftizoxime: an overall summary of clinical trials in Japan.
    Shimada J; Shimizu K
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():311-26. PubMed ID: 6296026
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of ceftizoxime in acute peritonitis.
    Lou MA; Chen DF; Bansal M; Balasubramaniam S; Thadepalli H
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():183-9. PubMed ID: 6296004
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients.
    Yangco BG; Baird I; Lorber B; Noble R; Bermudez R; Silverblatt F; Vasquez G
    J Antimicrob Chemother; 1987 Feb; 19(2):239-48. PubMed ID: 3553135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ceftizoxime in the treatment of paediatric infections.
    Shikuma CM; Cable DC; Edralin G; Overturf GD
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():293-5. PubMed ID: 6296023
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of ceftizoxime in neonates.
    Yamauchi T; Hill DE; Steele RW
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():297-301. PubMed ID: 6296024
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effectiveness of ceftizoxime on severe infections associated with hematologic disorders].
    Kanamaru A; Nagai K; Masaoka T; Shibata H; Kitani T; Taniguchi N; Horiuchi A; Hasegawa H; Kawagoe H; Hirata M
    Jpn J Antibiot; 1984 Jan; 37(1):136-44. PubMed ID: 6328059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of ceftizoxime in treating infections due to organisms resistant to other antibiotics.
    Neu HC
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():193-9. PubMed ID: 6296006
    [No Abstract]   [Full Text] [Related]  

  • 17. Ceftriaxone in the treatment of serious infections, particularly after surgery.
    Scully BE; Neu HC
    Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary report on the use of ceftizoxime vs. clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections.
    Harding G; Vincelette J; Rachlis A; Fong I; Mandell L; Feld R; Bailey D
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():191-2. PubMed ID: 6296005
    [No Abstract]   [Full Text] [Related]  

  • 19. Elimination of bacteria in biliary tract infections during ceftizoxime therapy.
    Helm EB; Wurbs D; Haag R; Bentele D; Shah PM
    Infection; 1982; 10(2):67-70. PubMed ID: 6284649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftizoxime in moderate-to-severe infections.
    Johnson ES; Smith LG
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():151-7. PubMed ID: 6296000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.